Pay in 4 interest-free payments of $5.17 Learn more
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
Eating Disorders When Eating Disorder Prevention Meets Corporate Profit: Navigating Complex Waters A call for broader dialogue in eating disorder treatment, exploring how narrative control affects patient care and professional growth
CTLA-4 and PD-1 receptors inhibit T-cell activation by distinct mechanisms
Tirzepatides 5 mg, 10 mg, and 15 mg doses showed A1C reductions of 2.01, 2.24 and 2.30, respectively, surpassing semaglutides 1.86 reduction at the 1 mg dose
Schizophrenia after prenatal faminefurther evidence
US$ 23.30
US$ 25.77
US$ 26.26
US$ 26.18
US$ 20.03
US$ 24.20
US$ 21.99
US$ 29.26
US$ 20.17
